Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration

Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 2010-05, Vol.77 (5), p.874-883
Hauptverfasser: Billa, Sophie K., Liu, Jie, Bjorklund, Nicole L., Sinha, Namita, Fu, Yu, Shinnick-Gallagher, Patricia, Morón, Jose A.
Format: Artikel
Sprache:eng
Schlagworte:
HFS
JST
LFS
LTD
LTP
PPF
PSD
PTX
VTA
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 883
container_issue 5
container_start_page 874
container_title Molecular pharmacology
container_volume 77
creator Billa, Sophie K.
Liu, Jie
Bjorklund, Nicole L.
Sinha, Namita
Fu, Yu
Shinnick-Gallagher, Patricia
Morón, Jose A.
description Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.
doi_str_mv 10.1124/mol.109.060301
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2872965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026895X24026804</els_id><sourcerecordid>20159947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EokNhyxJ5CQsPthPnZ4MUVdCONBVVAYmd5TjXHUNiW3amangrlrwEz4SrgREsWF1L99zvHOsg9JzRNWO8fD35cc1ou6YVLSh7gFZMcEYoY-whWlHKK9K04vMJepLSF0pZKRr6GJ1wykTblvUK_dg4HUElGPDGJYiz9Q57g8_H_awmNQO-Bg1h9hFzslX6q3U3-Od30k3WeVKQ3TJEf7cQQSaYd8tISmKTv1Pf_Aj4KvqQeVbjTtsBv-wur7pXR2DCasYXNgSv1RTUiD8sToUECe9DDnENAbL_gC99DDvrAHdDNrVpjuo-5VP0yKgxwbPf8xR9evf249kF2b4_35x1W6LLopkJU5qVfc95DaxVDVWqbnVT06ZXBTNcG2W46YuhEkIZXZpKQCl007dsANMbXZyiNwdu2PcTDBpcDjDKEO2k4iK9svLfjbM7eeNvJW9q3lYiA9YHgI4-pQjmeMuovC9R5hLzu5WHEvPBi78dj_I_rWVBcxBA_vethSiTtuA0DDaCnuXg7f_YvwD5arHr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Billa, Sophie K. ; Liu, Jie ; Bjorklund, Nicole L. ; Sinha, Namita ; Fu, Yu ; Shinnick-Gallagher, Patricia ; Morón, Jose A.</creator><creatorcontrib>Billa, Sophie K. ; Liu, Jie ; Bjorklund, Nicole L. ; Sinha, Namita ; Fu, Yu ; Shinnick-Gallagher, Patricia ; Morón, Jose A.</creatorcontrib><description>Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.109.060301</identifier><identifier>PMID: 20159947</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride ; 2-amino-5-phosphonovalerate ; ACSF ; AMPA ; AMPAR ; analysis of variance ; Animals ; ANOVA ; artificial cerebral spinal fluid ; CGP55845 ; d-APV ; EPSC ; excitatory postsynaptic currents ; Excitatory Postsynaptic Potentials - drug effects ; Excitatory Postsynaptic Potentials - physiology ; extracellular field excitatory postsynaptic potential ; fEPSP ; fiber volley ; GABA Antagonists - pharmacology ; HFS ; high-frequency stimulation ; immunoprecipitation ; Joro spider toxin ; JST ; LFS ; long-term depression ; long-term potentiation ; Long-Term Potentiation - drug effects ; Long-Term Potentiation - physiology ; low-frequency stimulation ; LTD ; LTP ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Morphine - pharmacology ; N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium ; N-methyl-d-aspartate ; N-methyl-d-aspartate receptor ; NMDA ; NMDAR ; paired-pulse facilitation ; philanthotoxin ; Phosphinic Acids - pharmacology ; Phosphorylation ; Phtx ; picrotoxin ; Picrotoxin - pharmacology ; postsynaptic density ; PPF ; Propanolamines - pharmacology ; Protein Subunits - drug effects ; Protein Subunits - genetics ; PSD ; PTX ; QX314 ; Receptors, AMPA - biosynthesis ; Receptors, AMPA - deficiency ; Receptors, AMPA - drug effects ; Receptors, AMPA - genetics ; Receptors, AMPA - physiology ; rectification index ; Synapses - drug effects ; Synapses - physiology ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology ; ventral tegmental area ; VTA ; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</subject><ispartof>Molecular pharmacology, 2010-05, Vol.77 (5), p.874-883</ispartof><rights>2010 American Society for Pharmacology and Experimental Therapeutics</rights><rights>Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</citedby><cites>FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20159947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Billa, Sophie K.</creatorcontrib><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Bjorklund, Nicole L.</creatorcontrib><creatorcontrib>Sinha, Namita</creatorcontrib><creatorcontrib>Fu, Yu</creatorcontrib><creatorcontrib>Shinnick-Gallagher, Patricia</creatorcontrib><creatorcontrib>Morón, Jose A.</creatorcontrib><title>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.</description><subject>(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride</subject><subject>2-amino-5-phosphonovalerate</subject><subject>ACSF</subject><subject>AMPA</subject><subject>AMPAR</subject><subject>analysis of variance</subject><subject>Animals</subject><subject>ANOVA</subject><subject>artificial cerebral spinal fluid</subject><subject>CGP55845</subject><subject>d-APV</subject><subject>EPSC</subject><subject>excitatory postsynaptic currents</subject><subject>Excitatory Postsynaptic Potentials - drug effects</subject><subject>Excitatory Postsynaptic Potentials - physiology</subject><subject>extracellular field excitatory postsynaptic potential</subject><subject>fEPSP</subject><subject>fiber volley</subject><subject>GABA Antagonists - pharmacology</subject><subject>HFS</subject><subject>high-frequency stimulation</subject><subject>immunoprecipitation</subject><subject>Joro spider toxin</subject><subject>JST</subject><subject>LFS</subject><subject>long-term depression</subject><subject>long-term potentiation</subject><subject>Long-Term Potentiation - drug effects</subject><subject>Long-Term Potentiation - physiology</subject><subject>low-frequency stimulation</subject><subject>LTD</subject><subject>LTP</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Morphine - pharmacology</subject><subject>N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium</subject><subject>N-methyl-d-aspartate</subject><subject>N-methyl-d-aspartate receptor</subject><subject>NMDA</subject><subject>NMDAR</subject><subject>paired-pulse facilitation</subject><subject>philanthotoxin</subject><subject>Phosphinic Acids - pharmacology</subject><subject>Phosphorylation</subject><subject>Phtx</subject><subject>picrotoxin</subject><subject>Picrotoxin - pharmacology</subject><subject>postsynaptic density</subject><subject>PPF</subject><subject>Propanolamines - pharmacology</subject><subject>Protein Subunits - drug effects</subject><subject>Protein Subunits - genetics</subject><subject>PSD</subject><subject>PTX</subject><subject>QX314</subject><subject>Receptors, AMPA - biosynthesis</subject><subject>Receptors, AMPA - deficiency</subject><subject>Receptors, AMPA - drug effects</subject><subject>Receptors, AMPA - genetics</subject><subject>Receptors, AMPA - physiology</subject><subject>rectification index</subject><subject>Synapses - drug effects</subject><subject>Synapses - physiology</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><subject>ventral tegmental area</subject><subject>VTA</subject><subject>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</subject><subject>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS0EokNhyxJ5CQsPthPnZ4MUVdCONBVVAYmd5TjXHUNiW3amangrlrwEz4SrgREsWF1L99zvHOsg9JzRNWO8fD35cc1ou6YVLSh7gFZMcEYoY-whWlHKK9K04vMJepLSF0pZKRr6GJ1wykTblvUK_dg4HUElGPDGJYiz9Q57g8_H_awmNQO-Bg1h9hFzslX6q3U3-Od30k3WeVKQ3TJEf7cQQSaYd8tISmKTv1Pf_Aj4KvqQeVbjTtsBv-wur7pXR2DCasYXNgSv1RTUiD8sToUECe9DDnENAbL_gC99DDvrAHdDNrVpjuo-5VP0yKgxwbPf8xR9evf249kF2b4_35x1W6LLopkJU5qVfc95DaxVDVWqbnVT06ZXBTNcG2W46YuhEkIZXZpKQCl007dsANMbXZyiNwdu2PcTDBpcDjDKEO2k4iK9svLfjbM7eeNvJW9q3lYiA9YHgI4-pQjmeMuovC9R5hLzu5WHEvPBi78dj_I_rWVBcxBA_vethSiTtuA0DDaCnuXg7f_YvwD5arHr</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Billa, Sophie K.</creator><creator>Liu, Jie</creator><creator>Bjorklund, Nicole L.</creator><creator>Sinha, Namita</creator><creator>Fu, Yu</creator><creator>Shinnick-Gallagher, Patricia</creator><creator>Morón, Jose A.</creator><general>Elsevier Inc</general><general>The American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201005</creationdate><title>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</title><author>Billa, Sophie K. ; Liu, Jie ; Bjorklund, Nicole L. ; Sinha, Namita ; Fu, Yu ; Shinnick-Gallagher, Patricia ; Morón, Jose A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-1ac14bb227e19a80aa79c8708ba31f2cfaf2fb3d655afc4f65e45c8b91defbfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride</topic><topic>2-amino-5-phosphonovalerate</topic><topic>ACSF</topic><topic>AMPA</topic><topic>AMPAR</topic><topic>analysis of variance</topic><topic>Animals</topic><topic>ANOVA</topic><topic>artificial cerebral spinal fluid</topic><topic>CGP55845</topic><topic>d-APV</topic><topic>EPSC</topic><topic>excitatory postsynaptic currents</topic><topic>Excitatory Postsynaptic Potentials - drug effects</topic><topic>Excitatory Postsynaptic Potentials - physiology</topic><topic>extracellular field excitatory postsynaptic potential</topic><topic>fEPSP</topic><topic>fiber volley</topic><topic>GABA Antagonists - pharmacology</topic><topic>HFS</topic><topic>high-frequency stimulation</topic><topic>immunoprecipitation</topic><topic>Joro spider toxin</topic><topic>JST</topic><topic>LFS</topic><topic>long-term depression</topic><topic>long-term potentiation</topic><topic>Long-Term Potentiation - drug effects</topic><topic>Long-Term Potentiation - physiology</topic><topic>low-frequency stimulation</topic><topic>LTD</topic><topic>LTP</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Morphine - pharmacology</topic><topic>N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium</topic><topic>N-methyl-d-aspartate</topic><topic>N-methyl-d-aspartate receptor</topic><topic>NMDA</topic><topic>NMDAR</topic><topic>paired-pulse facilitation</topic><topic>philanthotoxin</topic><topic>Phosphinic Acids - pharmacology</topic><topic>Phosphorylation</topic><topic>Phtx</topic><topic>picrotoxin</topic><topic>Picrotoxin - pharmacology</topic><topic>postsynaptic density</topic><topic>PPF</topic><topic>Propanolamines - pharmacology</topic><topic>Protein Subunits - drug effects</topic><topic>Protein Subunits - genetics</topic><topic>PSD</topic><topic>PTX</topic><topic>QX314</topic><topic>Receptors, AMPA - biosynthesis</topic><topic>Receptors, AMPA - deficiency</topic><topic>Receptors, AMPA - drug effects</topic><topic>Receptors, AMPA - genetics</topic><topic>Receptors, AMPA - physiology</topic><topic>rectification index</topic><topic>Synapses - drug effects</topic><topic>Synapses - physiology</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><topic>ventral tegmental area</topic><topic>VTA</topic><topic>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</topic><topic>α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Billa, Sophie K.</creatorcontrib><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Bjorklund, Nicole L.</creatorcontrib><creatorcontrib>Sinha, Namita</creatorcontrib><creatorcontrib>Fu, Yu</creatorcontrib><creatorcontrib>Shinnick-Gallagher, Patricia</creatorcontrib><creatorcontrib>Morón, Jose A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Billa, Sophie K.</au><au>Liu, Jie</au><au>Bjorklund, Nicole L.</au><au>Sinha, Namita</au><au>Fu, Yu</au><au>Shinnick-Gallagher, Patricia</au><au>Morón, Jose A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2010-05</date><risdate>2010</risdate><volume>77</volume><issue>5</issue><spage>874</spage><epage>883</epage><pages>874-883</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>Evidence suggests that the long-term adaptations in the hippocampus after repeated drug treatment may parallel its role during memory formation. The neuroplasticity that subserves learning and memory is also believed to underlie addictive processes. We have reported previously that repeated morphine administration alters local distribution of endocytic proteins at hippocampal synapses, which could in turn affect expression of glutamate receptors. Glutamatergic systems, including α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), are believed to be involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are only beginning to be understood. The present study further examines the effects of repeated morphine administration on the expression and composition of AMPARs and the functional ramifications. Twelve hours after the last morphine injection, we observed an increased expression of AMPARs lacking glutamate receptor (GluR) 2 in hippocampal synaptic fractions. Immunoblotting studies show that 12 h after morphine treatment, GluR1 subunits are increased at the postsynaptic density (PSD) and at extrasynaptic sites, whereas GluR3 subunits are only increased at the PSD, and they show how this alters receptor subunit composition. In addition, we provide electrophysiological evidence that AMPARs are switched to Ca2+-permeable (GluR2-lacking) at the synapse 12 h after repeated morphine treatment, affecting the magnitude of long-term depression at hippocampal neurons. We propose that morphine-induced changes in glutamatergic synaptic transmission in the hippocampus may play an important role in the neuroadaptations induced by repeated morphine administration.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20159947</pmid><doi>10.1124/mol.109.060301</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2010-05, Vol.77 (5), p.874-883
issn 0026-895X
1521-0111
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2872965
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects (2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride
2-amino-5-phosphonovalerate
ACSF
AMPA
AMPAR
analysis of variance
Animals
ANOVA
artificial cerebral spinal fluid
CGP55845
d-APV
EPSC
excitatory postsynaptic currents
Excitatory Postsynaptic Potentials - drug effects
Excitatory Postsynaptic Potentials - physiology
extracellular field excitatory postsynaptic potential
fEPSP
fiber volley
GABA Antagonists - pharmacology
HFS
high-frequency stimulation
immunoprecipitation
Joro spider toxin
JST
LFS
long-term depression
long-term potentiation
Long-Term Potentiation - drug effects
Long-Term Potentiation - physiology
low-frequency stimulation
LTD
LTP
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Morphine - pharmacology
N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium
N-methyl-d-aspartate
N-methyl-d-aspartate receptor
NMDA
NMDAR
paired-pulse facilitation
philanthotoxin
Phosphinic Acids - pharmacology
Phosphorylation
Phtx
picrotoxin
Picrotoxin - pharmacology
postsynaptic density
PPF
Propanolamines - pharmacology
Protein Subunits - drug effects
Protein Subunits - genetics
PSD
PTX
QX314
Receptors, AMPA - biosynthesis
Receptors, AMPA - deficiency
Receptors, AMPA - drug effects
Receptors, AMPA - genetics
Receptors, AMPA - physiology
rectification index
Synapses - drug effects
Synapses - physiology
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
ventral tegmental area
VTA
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
title Increased Insertion of Glutamate Receptor 2-Lacking α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors at Hippocampal Synapses upon Repeated Morphine Administration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T08%3A16%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Insertion%20of%20Glutamate%20Receptor%202-Lacking%20%CE%B1-Amino-3-hydroxy-5-methyl-4-isoxazole%20Propionic%20Acid%20(AMPA)%20Receptors%20at%20Hippocampal%20Synapses%20upon%20Repeated%20Morphine%20Administration&rft.jtitle=Molecular%20pharmacology&rft.au=Billa,%20Sophie%20K.&rft.date=2010-05&rft.volume=77&rft.issue=5&rft.spage=874&rft.epage=883&rft.pages=874-883&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.109.060301&rft_dat=%3Cpubmed_cross%3E20159947%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20159947&rft_els_id=S0026895X24026804&rfr_iscdi=true